IFT57 and cancer: This suggests that mechanisms mediating IFT57 coregulation with CD47 are intrinsic to cancer cells, but this does not exclude additional contributions from IFT57 co-expression with CD47 mRNA in nonmalignant cells in stroma of the tumors analyzed in TCGA.